StockData
Akari Therapeutics Plc logo

Akari Therapeutics Plc (AKTX) shareholders

AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 0/30
$5.70−0.81 (-12.44%)

Close on Nov 17, 2026Market cap $11.10MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.0%
0M of 155.76B shares
Institutional holders
9
5 new, 2 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Hoyoung Huh, M.D., Ph.D.18,199,697,66718.40%13G (passive) amendmentMar 2, 2026
Samir R. Patel9,725,215,00010.40%13D (active) amendmentMar 2, 2026
Ray Prudo, M.D.8,391,326,4678.90%13D (active) amendmentMar 2, 2026
Bmo Nesbitt Burns Inc.
Joint filing with Bank of Montreal (5.71%), Bank Of Montreal Holding Inc. (5.71%)
8,000,000,0005.71%13G (passive)Jun 30, 2026
MMCAP International Inc. SPC
Joint filing with MM Asset Management Inc. (8.00%)
8,000,000,0008.00%13G (passive)Jun 2, 2026
White Lion Capital LLC7,001,638,4775.00%13G (passive)Aug 7, 2026
Ray Prudo, M.D4,507,314,80019.20%13D (active) amendmentMay 31, 2024
Kathryn Theofilos
Joint filing with Charles Steve Theofilos, M.D (9.99%)
2,370,750,0009.99%13D (active)May 31, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of AKTXValueChange% of portfolio
MMCAP International Inc. SPC100,0000.00%$1.02MNew0.09%
Cresset Asset Management, LLC20,5610.00%$210.65K–0.00%
Jane Street Group, LLC15,4630.00%$158.42KNew0.00%
Hrt Financial LP13,7450.00%$140.00KNew0.00%
IFP Advisors, Inc1810.00%$1.85K−7,2500.00%
SBI Securities Co., Ltd.140.00%$143+90.00%
Caitong International Asset Management Co., Ltd80.00%$82New0.00%
Northwestern Mutual Wealth Management Co70.00%$72New0.00%
Truvestments Capital LLC10.00%$10–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202690M0.0%5 / 11 / 20M0M
Q1 202660M0.0%1 / 12 / 150M0M
Q4 2025210M0.0%9 / 31 / 40M0M
Q3 2025160M0.0%3 / 13 / 20M0M
Q2 2025150M0.0%5 / 02 / 10M0M
Q1 2025110M0.0%1 / 01 / 40M0M
Q4 2024140M0.0%5 / 10 / 10M0M
Q3 2024100M0.0%2 / 10 / 20M0M
Q2 2024100M0.0%4 / 10 / 20M0M
Q1 202480M0.0%2 / 10 / 10M0M
Q4 202370M0.0%2 / 11 / 20M0M
Q3 202370M0.0%7 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Abizer GaslightwalaCEO, Director41,1730.00%Oct 16, 2026
Vatnak Vat-HoChief Business Officer––Oct 14, 2026
Kameel D. FaragInterim CFO23,3090.00%Aug 19, 2026
Torsten HombeckCFO2000.00%Mar 24, 2025
Robert B. BazemoreDirector22,7590.00%Oct 16, 2026
Raymond Prudo-ChleboszDirector496,5990.00%Oct 16, 2026
Samir Rashmikant PatelDirector110,3430.00%Oct 16, 2026
Hoyoung HuhDirector, 10% owner250,2620.00%Oct 16, 2026
Sandip I. PatelDirector99,1270.00%Oct 16, 2026
James R. NealDirector36,2710.00%Mar 16, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Sandip I. Patel
Director
Oct 14, 2026Option exercise+6,186$0.00$238,877
Sandip I. Patel
Director
Oct 14, 2026Option exercise+3,866$0.00$232,691
Robert B. Bazemore
Director
Oct 14, 2026Option exercise+3,093$0.00$122,759
Robert B. Bazemore
Director
Oct 14, 2026Option exercise+773$0.00$019,666
Abizer Gaslightwala
CEO, Director
Oct 14, 2026Option exercise+7,733$0.00$341,173
Abizer Gaslightwala
CEO, Director
Oct 14, 2026Option exercise+19,333$0.00$833,440
Raymond Prudo-Chlebosz
Director
Oct 5, 2026Award+3,240$7.90$25.59K76,861
Hoyoung Huh
Director, 10% owner
Oct 5, 2026Award+6,160$7.90$48.66K140,805
Sandip I. Patel
Director
Oct 5, 2026Award+4,313$7.90$34.07K28,825
Robert B. Bazemore
Director
Oct 5, 2026Award+4,677$7.90$36.94K18,893
Samir Rashmikant Patel
Director
Oct 5, 2026Award+2,236$7.90$17.66K12,102
Abizer Gaslightwala
CEO, Director
Sep 29, 2026Award+6,430$9.72$62.50K14,107
Raymond Prudo-Chlebosz
Director
Aug 18, 2026Award+9,072$7.90$71.66K73,621
Hoyoung Huh
Director, 10% owner
Aug 18, 2026Award+17,249$7.90$136.25K134,645
Sandip I. Patel
Director
Aug 18, 2026Award+12,100$7.90$95.58K24,512
Robert B. Bazemore
Director
Aug 18, 2026Award+13,100$7.90$103.48K14,216
Samir Rashmikant Patel
Director
Aug 18, 2026Award+6,300$7.90$49.76K9,866
Kameel D. Farag
Interim CFO
Aug 17, 2026Award+1,728$7.52$12.99K23,309
Kameel D. Farag
Interim CFO
Jul 16, 2026Award+1,130$11.50$13.00K21,581
Samir Rashmikant Patel
Director, 10% owner
Jul 7, 2026Option exercise+5,799––98,241
Samir Rashmikant Patel
Director, 10% owner
Jul 7, 2026Option exercise+15,466––92,442
Samir Rashmikant Patel
Director, 10% owner
Jul 7, 2026Option exercise+1,209$8.00$9.67K76,976
Kameel D. Farag
Interim CFO
Jun 24, 2026Award+1,248$10.02$12.50K2,870
Kameel D. Farag
Interim CFO
Jun 24, 2026Award+1,395$9.32$13.00K4,265
Kameel D. Farag
Interim CFO
Jun 24, 2026Award+3,725$3.49$13.00K12,099
Kameel D. Farag
Interim CFO
Jun 24, 2026Award+2,539$5.12$13.00K8,374
Kameel D. Farag
Interim CFO
Jun 24, 2026Award+1,000$13.00$13.00K20,452
Kameel D. Farag
Interim CFO
Jun 24, 2026Award+7,353$3.74$27.50K19,452
Kameel D. Farag
Interim CFO
Jun 24, 2026Award+1,570$8.28$13.00K5,835
Kameel D. Farag
Interim CFO
Nov 1, 2025Award+32,000$0.75$24.00K32,000
Kameel D. Farag
Interim CFO
Nov 1, 2025Award+26,619$0.75$19.96K26,619
Kameel D. Farag
Interim CFO
Oct 22, 2025Award+6,277$0.74$4.64K6,277
Abizer Gaslightwala
CEO, Director
Aug 25, 2025Buy+3,000$0.90$2.70K298,574
Abizer Gaslightwala
CEO, Director
Aug 22, 2025Buy+8,000$0.93$7.44K295,574
Abizer Gaslightwala
CEO, Director
Aug 21, 2025Buy+10,000$0.94$9.40K287,574
Abizer Gaslightwala
President & CEO, Director
Jun 24, 2025Buy+5,203$1.16$6.04K277,574
Abizer Gaslightwala
President & CEO, Director
Jun 23, 2025Buy+943$1.15$1.08K272,371
Abizer Gaslightwala
President & CEO, Director
Jun 20, 2025Buy+10,000$1.20$12.00K271,428
Abizer Gaslightwala
President & CEO, Director
Jun 17, 2025Buy+15,000$1.20$18.00K261,428
Abizer Gaslightwala
CEO, Director
Jun 13, 2025Award+25,000$1.19$29.75K246,428
Abizer Gaslightwala
CEO, Director
Jun 12, 2025Award+20,000$1.23$24.60K221,428
Abizer Gaslightwala
CEO, Director
Jun 10, 2025Award+20,000$1.27$25.40K201,428
Sandip I. Patel
Director
Mar 6, 2025Award+44,642$1.12$50.00K496,499
Hoyoung Huh
Director, 10% owner
Mar 6, 2025Award+892,857$1.12$1,000.00K4,695,854
Samir Rashmikant Patel
Director
Mar 6, 2025Award+406,250$1.12$455.00K3,031,005
James R. Neal
Director
Mar 6, 2025Award+4,464$1.12$5.00K36,271
Abizer Gaslightwala
Director
Mar 6, 2025Award+133,928$1.12$150.00K181,428
Raymond Prudo-Chlebosz
Director
Mar 6, 2025Award+446,428$1.12$500.00K2,484,990
Robert B. Bazemore
Director
Mar 6, 2025Award+44,642$1.12$50.00K44,642
Abizer Gaslightwala
Director
Jan 10, 2025Award+11,640$1.22$14.20K47,500
Abizer Gaslightwala
Director
Jan 10, 2025Award+11,439$1.22$13.96K35,860
Torsten Hombeck
CFO
Jan 10, 2025Award+200$1.22$244200
James R. Neal
Director
Jan 9, 2025Award+8,000,000––32,216,000
Samir Rashmikant Patel
Director
Jan 3, 2025Award+208,000––5,249,511,500
Abizer Gaslightwala
Director
Jan 3, 2025Award+1,720,000––71,720,000
Abizer Gaslightwala
Director
Dec 27, 2024Award+40,000,000––70,000,000
Samir Rashmikant Patel
Director
Dec 27, 2024Award+400,000––5,249,303,500
Samir Rashmikant Patel
Director
Dec 26, 2024Award+3,200,000––5,248,903,500
Abizer Gaslightwala
Director
Dec 26, 2024Award+30,000,000––30,000,000
Samir Rashmikant Patel
Director
Dec 24, 2024Award+7,500,000––5,245,703,500

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+2.1%
From 0M shares
Short volume, 20 days
40.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Akari Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 5,517 shares on Aug 28, 2026 over the last 90 days.

See a number that looks wrong?